The 12th batch of national centralized drug procurement has concluded its first round of bidding, with 265 companies securing preliminary selection. Companies that did not win in the first round will have an opportunity for a second round of bidding to supply clinical needs. In other news, GigaDevice announced a share buyback plan of 1 to 2 billion yuan within six months, with a maximum repurchase price of 750 yuan per share, funded by its own capital. Additionally, ByteDance has established a new product team for its Doubao (Bean Pouch) application, signaling a focus on this area. AI
RANK_REASON The cluster contains multiple unrelated news items, including a policy update on drug procurement, a corporate financial announcement, and a product team formation, rather than a single cohesive event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
